Apalutamide use in metastatic hormone-sensitive prostate cancer patients diagnosed by conventional and next-generation imaging. Real world data from 772 patients
Titel:
Apalutamide use in metastatic hormone-sensitive prostate cancer patients diagnosed by conventional and next-generation imaging. Real world data from 772 patients
Auteur:
Hassi Roman, M. Mate, K. de Pablos-RodrIguez, P. Zamora Horcajada, Á. Guijarro Cascales, A. Sanchís Bonet, Á. Vilaseca, A. Vázquez-Martul Pazos, D. Linares Espinós, E. Muñoz Rodríguez, J. de la Morena Gallego, J.M. Alemán, J.R. Gómez Rivas, J. Formisano, L. Juan Fita, M.J. Costa Planells, M. Domínguez Esteban, M. Pérez Márquez, M. García Sanz, M. García Expósito, N. Picola, N. Servian Vives, P. Sopeña Sutil, R. Climent Durán, M.A. Ramírez Backhaus, M.